The selection of T cell clones with mutations in the hypoxanthine guanine phosphoribosyltransferase (hprt) gene has been used to isolate T cells reactive to myelin basic protein (MBP) 
Introduction
In experimental allergic encephalomyelitis (EAE),' discrete epitopes of myelin basic protein (MBP) have been identified, and disease can be induced by immunization with these peptides of MBP ( 1 ) or by transfer of T cell clones reactive to these peptides (2) . Despite the recognition of different encephalitogenic epitopes of MBP in the context of different major histocompatability complex (MHC) backgrounds in different species or strains of animals, encephalitogenic clones show a preference for use of certain TCR Va and ,Ps (3) (4) (5) . In BIO.PL mice, VP3
8.2 and Va 2.3 are used by encephalitogenic clones which recognize the NH2-terminal peptide residue 1-9 of MBP presented by I-AU. In Lewis rats, the recognition of MBP 68-88 in the context of I-A by encephalitogenic clones is carried out by T cell receptors (TCRs) homologous to VJ3 8.2 and Va 2. Restriction in TCR usage in pathogenic clones provided a rationale for therapies that prevent and reverse EAE with MHC class II-specific, or V,3 specific monoclonal antibodies (6) (7) (8) . The third complementarity determining region (CDR3) of TCR 1# chains expressed by these clones also show similarities, with conserved deduced amino acid motifs of DSGNTE, DSSNTE, or related sequences repeatedly observed in the rat clones responsive to MBP 68-88. To this end, TCR-directed peptide vaccines have been used successfully to prevent EAE (9, 10) . Because various selective regimens of immunotherapy aimed at MBP responsive T cells have shown great promise in EAE, efforts have been made to identify equivalent T cell clones in humans with MS.
The study of MBP-reactive T cells in humans has been enigmatic because MBP-reactive T cells can be detected in multiple sclerosis (MS) patients as well as in normal individuals. Studies exist which either support (11, 12) or refute (13) (14) (15) The size of amplified products using S '-V,/ and 3 '-C/3 primers ranged from 180 to 400 bp. Primers used in this study have been previously described (16 A) and deduced These PHA-activated clones were generated from the patient 11 clones from for which the hprt mutant T cell clones are described, and were lone designated. From studies using alanine-substitutec shown that the minimal residues nece; and T cell activation for Ac 
